Cellebrite DI Ltd. - Ordinary Shares (CLBT) SEC filings

CLBT SEC filings moved a median of +0.84% by the close. CLBT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CLBT overview →

44 measured CLBT SEC filing events.

Where these CLBT SEC filings landedvs 43 measured CLBT SEC filing reactions
CLBT SEC filingMiddle 50% · -0.47% to +2.98%Zero: 0.00%Median: +0.84%Median +0.84%-4.00%0+4.00%
Middle 50% of CLBT SEC filing reactions-0.47% to +2.98%
Median reaction (to close)+0.84%
Measured reactions43
Point-in-time · zero look-ahead

Half of the 43 CLBT SEC filing events with a measured close landed between -0.47% and +2.98%; 63% closed up.

DateHeadlineEvent5-minTo close
Form 6-K Cellebrite DI Ltd. For: Sep 24SEC filing · Form 6-K-0.40%-4.85%
Form 6-K Cellebrite DI Ltd. For: Sep 02SEC filing · Form 6-K+0.25%+0.84%
Form 6-K Cellebrite DI Ltd. For: Aug 18SEC filing · Form 6-K+1.75%+3.79%
Form 6-K Cellebrite DI Ltd. For: Aug 13SEC filing · Form 6-K-3.50%+5.16%
Form 6-K Cellebrite DI Ltd. For: Jun 30SEC filing · Form 6-K+2.13%+3.15%
Form 6-K Cellebrite DI Ltd. For: May 14SEC filing · Form 6-K+2.31%+8.43%
Cellebrite Files its 2025 Annual Report on Form 20-FPress release+0.36%+2.98%
Form 20-F Cellebrite DI Ltd. For: Dec 31SEC filing · Form 20-F+0.36%+2.98%
Form S-8 Cellebrite DI Ltd.SEC filing · Form S-8+0.36%+2.98%
Form 6-K Cellebrite DI Ltd. For: Feb 11SEC filing · Form 6-K-1.91%-2.60%
Form 6-K Cellebrite DI Ltd. For: Dec 02SEC filing · Form 6-K+0.99%+3.31%
Form 6-K Cellebrite DI Ltd. For: Nov 12SEC filing · Form 6-K-0.77%—
Form 6-K Cellebrite DI Ltd. For: Sep 22SEC filing · Form 6-K+0.06%+2.57%
Form 6-K Cellebrite DI Ltd. For: Aug 15SEC filing · Form 6-K+0.75%+1.89%
Form 6-K Cellebrite DI Ltd. For: Aug 14SEC filing · Form 6-K-3.74%+8.98%
Form 6-K Cellebrite DI Ltd. For: Jun 30SEC filing · Form 6-K+0.75%+1.89%
Form 6-K Cellebrite DI Ltd. For: Jul 08SEC filing · Form 6-K-0.86%+0.26%
Form 6-K Cellebrite DI Ltd. For: Jun 05SEC filing · Form 6-K+0.09%+1.20%
Form 6-K Cellebrite DI Ltd. For: May 14SEC filing · Form 6-K+8.43%+5.32%
Cellebrite Files its 2024 Annual Report on Form 20-FPress release-0.86%-0.16%
Form 20-F Cellebrite DI Ltd. For: Dec 31SEC filing · Form 20-F-0.86%-0.16%
Form 6-K Cellebrite DI Ltd. For: Feb 13SEC filing · Form 6-K-8.69%-12.71%
Form 6-K Cellebrite DI Ltd. For: Jan 06SEC filing · Form 6-K-0.49%-0.58%
Form 6-K Cellebrite DI Ltd. For: Nov 06SEC filing · Form 6-K+5.15%-2.10%
Form 6-K Cellebrite DI Ltd. For: Nov 04SEC filing · Form 6-K-0.70%+0.65%
Form 6-K Cellebrite DI Ltd. For: Sep 19SEC filing · Form 6-K+0.40%+0.40%
Form 6-K Cellebrite DI Ltd. For: Sep 18SEC filing · Form 6-K+0.37%-1.36%
Form 6-K Cellebrite DI Ltd. For: Sep 16SEC filing · Form 6-K-0.34%+0.06%
Form 6-K Cellebrite DI Ltd. For: Sep 06SEC filing · Form 6-K+0.46%-0.36%
Form 6-K Cellebrite DI Ltd. For: Aug 30SEC filing · Form 6-K+0.88%+0.53%
Form 6-K Cellebrite DI Ltd. For: Aug 27SEC filing · Form 6-K+0.92%+3.63%
Form 6-K Cellebrite DI Ltd. For: Aug 15SEC filing · Form 6-K-1.28%-4.10%
Form 6-K Cellebrite DI Ltd. For: Jun 30SEC filing · Form 6-K+0.35%+10.48%
Form 6-K Cellebrite DI Ltd. For: Aug 14SEC filing · Form 6-K+0.72%+0.94%
Form 6-K Cellebrite DI Ltd. For: Aug 13SEC filing · Form 6-K+0.72%+0.94%
Form 6-K Cellebrite DI Ltd. For: May 23SEC filing · Form 6-K+4.04%+3.30%
Form 20-F/A Cellebrite DI Ltd. For: Dec 31SEC filing · Form 20-F-0.01%-1.98%
Form 20-F Cellebrite DI Ltd. For: Dec 31SEC filing · Form 20-F-0.43%-0.34%
Form S-8 Cellebrite DI Ltd.SEC filing · Form S-8-0.43%-0.34%
Form 6-K Cellebrite DI Ltd. For: Mar 06SEC filing · Form 6-K-0.34%-1.70%
Form 6-K Cellebrite DI Ltd. For: Feb 15SEC filing · Form 6-K-3.40%+1.42%
Form 6-K Cellebrite DI Ltd. For: Dec 01SEC filing · Form 6-K-0.84%+1.68%
Form 6-K Cellebrite DI Ltd. For: Nov 14SEC filing · Form 6-K-5.73%-3.16%
Form 6-K Cellebrite DI Ltd. For: Oct 24SEC filing · Form 6-K-1.01%-2.16%
That’s how CLBT usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More CLBT: earnings → · analyst actions → · CLBT overview →